Your browser doesn't support javascript.
loading
Impact of TP53 mutations in Triple Negative Breast Cancer.
Mitri, Zahi I; Abuhadra, Nour; Goodyear, Shaun M; Hobbs, Evthokia A; Kaempf, Andy; Thompson, Alastair M; Moulder, Stacy L.
Affiliation
  • Mitri ZI; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. mitri@ohsu.edu.
  • Abuhadra N; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Goodyear SM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Hobbs EA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Kaempf A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Thompson AM; Baylor College of Medicine, Houston, TX, USA.
  • Moulder SL; Eli Lilly and Company, Indianapolis, IN, USA.
NPJ Precis Oncol ; 6(1): 64, 2022 Sep 09.
Article in En | MEDLINE | ID: mdl-36085319
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country: